Back to search
Prevention of Subclinical Atherosclerosis Progression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Subclinical Atherosclerosis Progression trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Subclinical Atherosclerosis Progression trials you may qualify forThe potential for nattokinase to "thin" blood and to reduce blood clotting by positive antithrombotic and fibrinolytic effects presents a unique opportunity to…
The purpose of this study is to determine whether soy supplementation can reduce hardening of the arteries and cognitive decline in postmenopausal women.